Cardio Diagnostics Holdings Inc
NASDAQ:CDIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO
|
US |
|
G
|
GeneralFinance SpA
MIL:GF
|
IT |
|
Andfjord Salmon AS
OSE:ANDF
|
NO |
Balance Sheet
Balance Sheet Decomposition
Cardio Diagnostics Holdings Inc
Cardio Diagnostics Holdings Inc
Balance Sheet
Cardio Diagnostics Holdings Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
1
|
4
|
1
|
8
|
5
|
|
| Cash |
0
|
1
|
4
|
1
|
8
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
1
|
1
|
1
|
|
| Total Current Assets |
0
|
1
|
6
|
3
|
9
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+144%
|
6
+468%
|
4
-29%
|
11
+138%
|
8
-27%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
2
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-92%
|
2
+6 400%
|
2
-23%
|
1
-30%
|
1
-25%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
1
|
6
|
14
|
23
|
29
|
|
| Additional Paid In Capital |
1
|
2
|
10
|
17
|
32
|
36
|
|
| Total Equity |
0
N/A
|
1
+1 683%
|
4
+302%
|
3
-31%
|
10
+223%
|
7
-27%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+144%
|
6
+468%
|
4
-29%
|
11
+138%
|
8
-27%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
0
|
0
|
0
|
1
|
2
|
2
|
|